Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 10:34 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2569–2592 of 21,991 matching trials from the live ClinicalTrials.gov search.

Filters: Recruiting Clear all

Conditions: Cancer Risk
Interventions: Biospeciman Collection, Survey Assessments, Medical Chart Reviews; Procedure · Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 20,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2037
U.S. locations: 6
States / cities: Aurora, Colorado • Colorado Springs, Colorado • Denver, Colorado + 2 more

Conditions: CNS Tumors, Meningioma, Esthesioneuroblastoma, Hemangioblastoma, Medulloblastoma, Paraganglioma, Pituitary Adenoma
Interventions: Ga68-DOTATATE-PET/MRI; Diagnostic Test
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2038
U.S. locations: 1
States / cities: New York, New York

Conditions: Basal Cell Carcinoma (BCC)
Interventions: aminolevulinic acid HCL (ALA), BLU-U device model 4170E; Drug · Device
Lead sponsor: Nathalie Zeitouni; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Short Interpregnancy Intervals, Maternal Health Disparities
Interventions: Joint contraceptive and couple communication education, Couple communication consultation with Interventionist to increase partner engagement and improve communication, Check-ins to support continued partner support & communication; Other
Lead sponsor: University of Tennessee Graduate School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Knoxville, Tennessee

Conditions: Pregnancy, Sedentary Behavior, Insufficient Physical Activity
Interventions: Sit Less, Move More (SLMM) for pregnant women; Behavioral
Lead sponsor: University of Central Florida; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Locally Advanced Oral Cavity Squamous Cell Carcinoma, Locally Recurrent Oral Cavity Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma
Interventions: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, Pembrolizumab, Photon Stereotactic Body Radiation Therapy, Positron Emission Tomography, Spatially-fractionated Radiation Therapy, Surgical Procedure; Procedure · Biological · Radiation
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Gastroparesis
Interventions: Not listed
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2026
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Localized Breast Carcinoma
Interventions: Lymphedema Management, Questionnaire Administration, Adjuvant breast radiation therapy; Other · Radiation
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years and older · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Depression
Interventions: pregnenolone, placebo; Dietary Supplement · Other
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 40 Years to 60 Years · Female only
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Epilepsy
Interventions: Tripolar electroencephalography; Device
Lead sponsor: CREmedical; Industry
Eligibility: 6 Years and older
Enrollment: 90 participants
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Phoenix, Arizona • Boston, Massachusetts

Conditions: B-cell Acute Lymphoblastic Leukemia, B-cell Non Hodgkin Lymphoma
Interventions: CD19CAR-CD3Zeta-4-1BB-Expressing Autologous T-Lymphocyte Cells; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 31 Days to 30 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2031
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Gastric Cancer, Invasive Breast Cancer, in Situ Breast Cancer, Mantle Cell Lymphoma, Larynx Cancer, Bladder Cancer
Interventions: Viewray MRIdian® Linac; Radiation
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2029
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Pancreatic Cancer, Pancreatic Neoplasms, Diabetes Mellitus
Interventions: MRI/MRCP; Diagnostic Test
Lead sponsor: Nuvance Health; Other
Eligibility: 50 Years and older
Enrollment: 800 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2028
U.S. locations: 2
States / cities: New Haven, Connecticut • Norwalk, Connecticut

Conditions: Articular Cartilage Defect, Articular Cartilage Degeneration
Interventions: Autologous Chondrocyte Implantation (CartiLife®); Drug
Lead sponsor: Biosolution Co., Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 5
States / cities: Irvine, California • La Mesa, California • Lafayette, Louisiana + 1 more

Conditions: Cancer
Interventions: Retrospective Populations; Other
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 99 Years
Enrollment: 10,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2032
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Injury of Ureter During Surgery (Disorder)
Interventions: Nizaracianine Triflutate, Placebo Comparator; Drug
Lead sponsor: Curadel Surgical Innovations, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 336 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 5
States / cities: Los Angeles, California • Redwood City, California • Orlando, Florida + 2 more

Conditions: Obesity, Overweight
Interventions: LY4174794, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 116 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 2
States / cities: San Antonio, Texas • Salt Lake City, Utah

Conditions: Diabetes Mellitus
Interventions: InPen Smart insulin pen, traditional/standard insulin pen; Device · Other
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 2
States / cities: Baltimore, Maryland

Conditions: Pulmonary Arterial Hypertension
Interventions: Sotatercept; Drug
Lead sponsor: Merck Sharp & Dohme LLC; Industry
Eligibility: 1 Year to 17 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 10
States / cities: Los Angeles, California • Palo Alto, California • San Francisco, California + 7 more

Conditions: Discogenic Low Back Pain
Interventions: PerQdisc; Device
Lead sponsor: Spinal Stabilization Technologies; Industry
Eligibility: 22 Years to 70 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 8
States / cities: Glendale, Arizona • Phoenix, Arizona • Scottsdale, Arizona + 4 more

Conditions: Hemophilia A, Hemophilia A, Severe, Factor VIII (FVIII), FVIII Deficiency, Carrier of Hemophilia A, Inhibitors, Pregnancy, Maternal Blood Loss, Pregnancy Complications, Bleeding Disorder, Hemorrhage, Postpartum, Alloimmunization, X-Linked
Interventions: Not listed
Lead sponsor: University of Washington; Other
Eligibility: Not listed
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: X-linked Hypophosphatemia
Interventions: KK8123; Drug
Lead sponsor: Kyowa Kirin Co., Ltd.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2030
U.S. locations: 5
States / cities: San Francisco, California • New Haven, Connecticut • Indianapolis, Indiana + 2 more

Conditions: ADNP, Helsmoortel-Van Der Aa Syndrome, Autism Spectrum Disorder
Interventions: Not listed
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 2 Years and older
Enrollment: 30 participants
Timeline: 2017 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Lower Back Pain
Interventions: CNTX-3001, Placebo; Drug
Lead sponsor: Centrexion Therapeutics; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Napa, California

Search by objective public record fields.

A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer

68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.

Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell Carcinomas

Planning Together: A Couple-based, Multi-level Prenatal Contraceptive Education Program for Economically Marginalized Families

Effectiveness of Interventions to Promote Physical Activity During Pregnancy

Proton Spatially Fractionated Radiotherapy or Photon Stereotactic Body Radiotherapy in Combination With Pembrolizumab Before Surgery for the Treatment of Locally Advanced and Radiation-Naive Locoregionally Recurrent Oral Cavity Cancer, OSPRI Trial

Gastric Per-Oral Endoscopic Myotomy (G-POEM) for the Treatment of Gastroparesis

Manual Lymphatic Drainage Breast Massage in Breast Cancer Patients After Breast Conserving Surgery

Study on Allopregnanolone and Depression in Women Across the Menopause Transition

Epilepsy Seizure Detection With Innovative Tripolar EEG (tEEG)

UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL

CONFIRM: Magnetic Resonance Guided Radiation Therapy

A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus

Phase 2 Clinical Trial of CartiLife® in the United States

Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated With Radiation

Trial to Visualize the Ureters With Nizaracianine Triflutate in Adults Undergoing Abdominopelvic Surgery

A Study of LY4174794 in Participants With Obesity or Overweight Who Are Otherwise Healthy

Improving Glycemic Control With Telemedicine and Smart Insulin Pens

Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)

PerQdisc Traditional Feasibility Trial.

Hemophilia A Research Program

A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia

ADNP Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing ADNP-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures.

Safety and PK of Intrathecal CNTX-3001 for Intractable Chronic Low Back Pain